Filtered By:
Source: EurekAlert! - Medicine and Health
Countries: Sweden Health

This page shows you your search results in order of date.

Order by Relevance | Date

Total 4 results found since Jan 2013.

Researchers successfully repair stroke-damaged rat brains
(Lund University) Researchers at Lund University in Sweden have succeeded in restoring mobility and sensation of touch in stroke-afflicted rats by reprogramming human skin cells to become nerve cells, which were then transplanted into the rats' brains. The study has now been published in the research journal PNAS.
Source: EurekAlert! - Medicine and Health - April 8, 2020 Category: International Medicine & Public Health Source Type: news

Statin use reduces mortality and stroke risk in dementia patients, new study shows
(Spink Health) The study, which analyzed 44,920 Swedish dementia patients from the Swedish Dementia Registry between 2008-2015, found users of statins had a 22% lower risk of all-cause death compared to matched non-users. The research also demonstrated that statin users had a 23% reduction in the risk of stroke, which is three times more likely in patients with mild dementia and seven times more likely in those with severe dementia.
Source: EurekAlert! - Medicine and Health - June 30, 2019 Category: International Medicine & Public Health Source Type: news

Correlation of stroke and dementia with death: A study from the Swedish dementia registry
(Bentham Science Publishers) Patients who died of IS the most common type of dementia was vascular dementia while those died from other causes were most often diagnosed with Alzheimer's dementia (AD). Patients who died from IS and were registered in Riksstroke had higher MMSE score compared to other groups. Patients who died from IS took more cardiovascular medications. There were no differences in the use of antipsychotics, antidepressants, acetylcholinesterase inhibitors, memantine, anxiolytics, or hypnotics between the groups.
Source: EurekAlert! - Medicine and Health - December 14, 2018 Category: International Medicine & Public Health Source Type: news

Diabetes drug liraglutide linked to lower risk of cardiovascular events
(Karolinska Institutet) Real world data from a large Nordic study shows that use of liraglutide, a drug for type 2 diabetes, is associated with a lower risk of myocardial infarction, stroke or cardiovascular death. The study, led by researchers from Karolinska Institutet in Sweden, is published in The Lancet Diabetes& Endocrinology.
Source: EurekAlert! - Medicine and Health - December 5, 2018 Category: International Medicine & Public Health Source Type: news